UnitedHealth Group Q2 2024 10-Q Filing

TL;DR

UNH filed Q2 10-Q. Financials look solid.

AI Summary

UnitedHealth Group Inc. filed its 10-Q for the period ending June 30, 2024. The filing covers the second quarter of 2024, detailing financial performance and operational updates. Key financial data and segment information are presented for the reporting period and comparative periods.

Why It Matters

This filing provides investors and analysts with the latest financial results and operational details for UnitedHealth Group, a major player in the healthcare industry.

Risk Assessment

Risk Level: low — This is a routine quarterly financial filing from a large, established company.

Key Numbers

• 2024 Q2 — Reporting Period (Second quarter of 2024 financial data)
• 2024-06-30 — As of Date (End of the reporting period)
• 2023-12-31 — Prior Year End (Reference point for year-over-year comparisons)

Key Players & Entities

• UNITEDHEALTH GROUP INC (company) — Filer of the 10-Q
• 0000731766 (company) — Central Index Key for UnitedHealth Group
• 20240630 (date) — Conformed Period of Report
• 20240809 (date) — Filing Date

FAQ

Filing Documents

• unh-20240630.htm (10-Q) — 1607KB
• ex311unh2024630.htm (EX-31.1) — 19KB
• ex321unh2024630.htm (EX-32.1) — 9KB
• unh-20240630_g1.jpg (GRAPHIC) — 16KB
• 0000731766-24-000262.txt ( ) — 7974KB
• unh-20240630.xsd (EX-101.SCH) — 32KB
• unh-20240630_cal.xml (EX-101.CAL) — 86KB
• unh-20240630_def.xml (EX-101.DEF) — 247KB
• unh-20240630_lab.xml (EX-101.LAB) — 559KB
• unh-20240630_pre.xml (EX-101.PRE) — 397KB
• unh-20240630_htm.xml (XML) — 1423KB

Financial Information

Part I. Financial Information Item 1.

Financial Statements (unaudited)

Financial Statements (unaudited) 1 Condensed Consolidated Balance Sheets as of June 3 0 , 2024 and December 31, 2023 1 Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30 , 2024 and 2023 2 Condensed Consolidated Statements of Comprehensive Income for the Three an d Six Months Ended June 3 0 , 2024 and 2023 3 Condensed Consolidated Statements of Changes in Equity for the Three and Six Months Ended June 3 0 , 2024 and 2023 4 Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 3 0 , 2024 and 2023 6 Notes to the Condensed Consolidated Financial Statements 7 1. Basis of Presentation 7 2. Investments 8 3. Fair Value 10 4. Medical Costs Payable 11 5. Short-Term Borrowings and Long-Term Debt 12 6. Shareholder ' s Equity 12 7. Commitments and Contingencies 13 8. Disposition and Held for Sale 14 9. Segment Financial Information 15 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 17 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 26 Item 4.

Controls and Procedures

Controls and Procedures 26

Other Information

Part II. Other Information Item 1.

Legal Proceedings

Legal Proceedings 26 Item 1A.

Risk Factors

Risk Factors 26 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 27 Item 5. Other Information 27 Item 6. Exhibits 27

Signatures

Signatures 28 PART I

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS UnitedHealth Group Condensed Consolidated Balance Sheets (Unaudited) (in millions, except per share data) June 30, 2024 December 31, 2023 Assets Current assets: Cash and cash equivalents $ 26,286 $ 25,427 Short-term investments 5,037 4,201 Accounts receivable, net 23,115 21,276 Other current receivables, net 26,762 17,694 Assets under management 3,414 3,755 Prepaid expenses and other current assets 7,424 6,084 Total current assets 92,038 78,437 Long-term investments 46,113 47,609 Property, equipment and capitalized software, net 9,801 11,450 Goodwill 105,436 103,732 Other intangible assets, net 14,729 15,194 Other assets 17,939 17,298 Total assets $ 286,056 $ 273,720 Liabilities, redeemable noncontrolling interests and equity Current liabilities: Medical costs payable $ 32,547 $ 32,395 Accounts payable and accrued liabilities 30,886 31,958 Short-term borrowings and current maturities of long-term debt 11,371 4,274 Unearned revenues 2,572 3,355 Other current liabilities 27,294 27,072 Total current liabilities 104,670 99,054 Long-term debt, less current maturities 63,727 58,263 Deferred income taxes 3,631 3,021 Other liabilities 14,794 14,463 Total liabilities 186,822 174,801 Commitments and contingencies (Note 7) Redeemable noncontrolling interests 4,558 4,498 Equity: Preferred stock, $ 0.001 par value - 10 shares authorized; no shares issued or outstanding — — Common stock, $ 0.01 par value - 3,000 shares authorized; 921 and 924 issued and outstanding 9 9 Additional paid-in capital 373 — Retained earnings 92,400 95,774 Accumulated other comprehensive loss ( 3,423 ) ( 7,027 ) Nonredeemable noncontrolling interests 5,317 5,665 Total equity 94,676 94,421 Total liabilities, redeemable noncontrolling interests and equity $ 286,056 $ 273,720 See Notes to the Condensed Consolidated Financial Statements 1 Table of Contents UnitedHealth Group Condensed Consolidated Statements of Operations

View Full Filing

View this 10-Q filing on SEC EDGAR